Trulieve rang the NYSE closing bell — the first cannabis company ever to do it

CEO Kim Rivers and Trulieve's board rang the NYSE closing bell at 4 p.m. Eastern on August 18, marking two months of trading under ticker TRLV since the company's June 10 listing — the first U.S. cannabis operator ever to trade on the New York Stock Exchange rather than the OTC markets or a Canadian venue.

The numbers behind the ceremony: 207 medical dispensaries across Florida, Georgia, Pennsylvania and West Virginia, about 3.5 million square feet of cultivation and production space, $109 million in operating cash flow through the first half of 2026, and $325 million in cash at the end of Q2. All 207 stores are now DEA-registered following the state-legal medical cannabis move to Schedule III in April.

Most multistate operators still trade over-the-counter or on Canadian exchanges because of marijuana's federal status — Trulieve's uplisting is the clearest proof yet that a U.S. exchange will take a cannabis company under current rules, and it raises the pressure on peers like Curaleaf and Green Thumb, both of which have their own reasons to want institutional-grade liquidity this year.

One listing doesn't mean the sector has normalized. Full adult-use rescheduling still hasn't happened — the DEA's paperwork phase runs well into the fall, at minimum — and most MSOs remain shut out of major indexes and mutual funds that restrict Schedule I-adjacent holdings. Trulieve's bell-ringing is a milestone, not the finish line.